MMP2 and non-small cell lung carcinoma: Upregulation of the MMP-2 in the fibroblasts neighboring the tumor was observed in about 50% of the NSCLC patients, enabling malignant transformation by ECM degradation and the creation of a suitable microenvironment for vessel growth [43].